S&P 500   4,585.59
DOW   36,117.38
QQQ   390.43
Forward dividend yield: What it is and how to use it 
Recent Reports Are A Wake-Up Call For Investors (Ad)
What are consumer staples stocks?
Healthcare sector: Overview and keys to investing
Recent Reports Are A Wake-Up Call For Investors (Ad)
Is Amazon a blue chip stock?
How to find penny stocks to invest and trade 
The Battery Metal Nobody Told You About (Ad)
How to invest in GTE technology: A guide 
Consumer staples vs. consumer discretionary
S&P 500   4,585.59
DOW   36,117.38
QQQ   390.43
Forward dividend yield: What it is and how to use it 
Recent Reports Are A Wake-Up Call For Investors (Ad)
What are consumer staples stocks?
Healthcare sector: Overview and keys to investing
Recent Reports Are A Wake-Up Call For Investors (Ad)
Is Amazon a blue chip stock?
How to find penny stocks to invest and trade 
The Battery Metal Nobody Told You About (Ad)
How to invest in GTE technology: A guide 
Consumer staples vs. consumer discretionary
S&P 500   4,585.59
DOW   36,117.38
QQQ   390.43
Forward dividend yield: What it is and how to use it 
Recent Reports Are A Wake-Up Call For Investors (Ad)
What are consumer staples stocks?
Healthcare sector: Overview and keys to investing
Recent Reports Are A Wake-Up Call For Investors (Ad)
Is Amazon a blue chip stock?
How to find penny stocks to invest and trade 
The Battery Metal Nobody Told You About (Ad)
How to invest in GTE technology: A guide 
Consumer staples vs. consumer discretionary
S&P 500   4,585.59
DOW   36,117.38
QQQ   390.43
Forward dividend yield: What it is and how to use it 
Recent Reports Are A Wake-Up Call For Investors (Ad)
What are consumer staples stocks?
Healthcare sector: Overview and keys to investing
Recent Reports Are A Wake-Up Call For Investors (Ad)
Is Amazon a blue chip stock?
How to find penny stocks to invest and trade 
The Battery Metal Nobody Told You About (Ad)
How to invest in GTE technology: A guide 
Consumer staples vs. consumer discretionary

Soleno Therapeutics (SLNO) News Today

$37.01
+2.95 (+8.66%)
(As of 12/7/2023 ET)
Compare
Today's Range
$33.89
$38.11
50-Day Range
$21.93
$37.01
52-Week Range
$0.85
$38.20
Volume
518,072 shs
Average Volume
394,151 shs
Market Capitalization
$1.13 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$38.00
SourceHeadline
MarketBeat logoSoleno Therapeutics, Inc. (NASDAQ:SLNO) CFO James H. Mackaness Sells 4,186 Shares of Stock
americanbankingnews.com - December 5 at 5:24 AM
MarketBeat logoSoleno Therapeutics, Inc. (NASDAQ:SLNO) CEO Bhatnagar Anish Sells 27,716 Shares of Stock
americanbankingnews.com - December 5 at 4:28 AM
MarketBeat logoSoleno Therapeutics, Inc. (NASDAQ:SLNO) CEO Sells $696,387.36 in Stock
americanbankingnews.com - December 3 at 4:37 AM
MarketBeat logoSoleno Therapeutics (NASDAQ:SLNO) Sets New 52-Week High at $30.42
americanbankingnews.com - December 3 at 3:19 AM
finance.yahoo.com logoInsider Sell Alert: CFO James Mackaness Sells 8,081 Shares of Soleno Therapeutics Inc (SLNO)
finance.yahoo.com - December 1 at 9:03 AM
finance.yahoo.com logo3 Biotech Stocks With Big-Time Breakthrough Potential
finance.yahoo.com - November 28 at 2:19 AM
seekingalpha.com logoSoleno Therapeutics: Impressive Data, But Never Forget Amarin
seekingalpha.com - November 26 at 12:37 PM
markets.businessinsider.com logo4 Analysts Have This to Say About Soleno Therapeutics
markets.businessinsider.com - November 21 at 3:34 PM
markets.businessinsider.com logoUndervalued Potential: Soleno Therapeutics’ Promising Prospects and Upward Price Target Revision
markets.businessinsider.com - November 10 at 7:10 PM
morningstar.com logoSoleno Therapeutics Inc SLNO
morningstar.com - November 7 at 9:59 AM
finance.yahoo.com logoSoleno Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results
finance.yahoo.com - November 7 at 9:59 AM
msn.com logoSoleno Therapeutics (SLNO) Price Target Increased by 14.43% to 37.74
msn.com - November 3 at 10:14 AM
finance.yahoo.com logoThe Ten Most-Shorted Stocks Include Huge Market Movers In 2023
finance.yahoo.com - October 16 at 10:54 AM
finance.yahoo.com logoXerox, Mastercraft Boat, and More Stocks See Action From Activist Investors
finance.yahoo.com - October 6 at 11:22 PM
msn.com logoSoleno Therapeutics (SLNO) Price Target Increased by 162.16% to 32.98
msn.com - October 5 at 10:21 AM
finance.yahoo.com logoSoleno Therapeutics Announces DCCR Data Presentation at the Foundation for Prader-Willi Research Symposium
finance.yahoo.com - October 4 at 6:19 PM
finance.yahoo.com logoCorrecting & Replacing -- Soleno Therapeutics Announces DCCR Data Presentation at the Foundation for Prader-Willi Research Symposium
finance.yahoo.com - October 4 at 6:19 PM
msn.com logoMeet Soleno Therapeutics, The Company Whose Hunger Suppressant Sent Shares Flying 505%
msn.com - October 3 at 10:22 AM
finance.yahoo.com logoSoleno Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Concurrent Private Placement of Common Stock and Pre-Funded Warrants and Full Exercise of Underwriters’ Option to Purchase Additional Shares
finance.yahoo.com - October 2 at 6:46 PM
msn.com logoSoleno Therapeutics' 10% owner buys $15M worth of stock
msn.com - September 29 at 4:06 PM
marketbeat.com logoSoleno Therapeutics, Inc. (NASDAQ:SLNO) Major Shareholder Perceptive Advisors Llc Buys 250,000 Shares
marketbeat.com - September 29 at 3:20 PM
finance.yahoo.com logoSoleno Therapeutics Announces Proposed Public Offering of Common Stock and/or Pre-Funded Warrants and a Concurrent Private Placement of Common Stock and/or Pre-Funded Warrants
finance.yahoo.com - September 27 at 8:10 PM
finance.yahoo.com logoWhy Shares of Soleno Therapeutics Dropped on Wednesday
finance.yahoo.com - September 27 at 8:10 PM
finance.yahoo.com logoSoleno Therapeutics Stock Dives After Its Meteoric Rise on Positive Study Results
finance.yahoo.com - September 27 at 3:09 PM
finance.yahoo.com logoIndividual investors in Soleno Therapeutics, Inc. (NASDAQ:SLNO) are its biggest bettors, and their bets paid off as stock gained 494% last week
finance.yahoo.com - September 27 at 10:08 AM
finance.yahoo.com logoSoleno (SLNO) Soars as Prader-Willi Syndrome Study Meets Goal
finance.yahoo.com - September 27 at 10:08 AM
marketwatch.com logoSoleno Therapeutics Shares Take Flight After Strong Study Data
marketwatch.com - September 26 at 6:24 PM
markets.businessinsider.com logoSoleno Therapeutics' Study Outcome Bolsters Confidence In PWS Treatment
markets.businessinsider.com - September 26 at 6:24 PM
finance.yahoo.com logoSoleno Catapults 505% After Its Pill Controls Hunger In Obesity-Causing Genetic Disease
finance.yahoo.com - September 26 at 6:24 PM
markets.businessinsider.com logoSoleno Says Study C602 Met Primary Endpoint; Stock Surges In Premarket
markets.businessinsider.com - September 26 at 1:24 PM
msn.com logoGenetic Disorder Focused Soleno Therapeutics' Stock Is Trading 4X Today - Here's Why?
msn.com - September 26 at 1:24 PM
finance.yahoo.com logoSoleno Catapults Almost 400% After Its Pill Controls Hunger In Obesity-Causing Genetic Disease
finance.yahoo.com - September 26 at 1:24 PM
finance.yahoo.com logoWhy Shares of Soleno Therapeutics Are Booming on Tuesday
finance.yahoo.com - September 26 at 1:24 PM
investorplace.com logoWhy Is Soleno Therapeutics (SLNO) Stock Up 420% Today?
investorplace.com - September 26 at 1:06 PM
marketbeat.com logo
marketbeat.com - September 26 at 10:20 AM
marketbeat.com logo
marketbeat.com - September 26 at 10:10 AM
marketbeat.com logo
marketbeat.com - September 26 at 9:57 AM
marketbeat.com logo
marketbeat.com - September 26 at 9:48 AM
marketbeat.com logo
marketbeat.com - September 26 at 9:37 AM
marketwatch.com logoSoleno Therapeutics Shares Soar Premarket on Prader-Willi Study Success
marketwatch.com - September 26 at 8:24 AM
finance.yahoo.com logoSoleno Therapeutics Announces Positive Statistically Significant Top-line Results from Randomized Withdrawal Period of Study C602 of DCCR for Prader-Willi Syndrome
finance.yahoo.com - September 26 at 8:24 AM
finance.yahoo.com logoSoleno Therapeutics to Present at the Cantor Global Healthcare Conference
finance.yahoo.com - September 25 at 9:41 AM
msn.com logoOppenheimer Maintains Soleno Therapeutics (SLNO) Outperform Recommendation
msn.com - September 15 at 2:10 PM
markets.businessinsider.com logoOppenheimer Maintains Outperform Rating for Soleno Therapeutics: Here's What You Need To Know
markets.businessinsider.com - September 15 at 2:10 PM
nasdaq.com logoCantor Fitzgerald Reiterates Soleno Therapeutics (SLNO) Overweight Recommendation
nasdaq.com - September 1 at 9:22 AM
finance.yahoo.com logoSoleno Therapeutics Announces Appointment of Industry Veteran Matthew Pauls, J.D., M.B.A. to Board of Directors
finance.yahoo.com - August 16 at 9:12 AM
msn.com logoSoleno Therapeutics (SLNO) Price Target Increased by 37.04% to 12.58
msn.com - August 2 at 7:07 AM
markets.businessinsider.com logoKeep The Hunger On: Analyst Says Soleno Therapeutics' Upside Potential Much Higher Than Downside Risk
markets.businessinsider.com - July 11 at 5:20 PM
finance.yahoo.com logoLL Flooring and Ingevity Stock See Action From Activist Investors
finance.yahoo.com - June 2 at 10:06 PM
benzinga.com logoMassive Insider Trade At Soleno Therapeutics
benzinga.com - June 2 at 12:04 PM
Get Soleno Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for SLNO and its competitors with MarketBeat's FREE daily newsletter.



SLNO Media Mentions By Week

SLNO Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

SLNO
News Sentiment

-0.73

0.51

Average
Medical
News Sentiment

SLNO News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

SLNO Articles
This Week

10

1

SLNO Articles
Average Week

Get Soleno Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for SLNO and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:SLNO) was last updated on 12/8/2023 by MarketBeat.com Staff

My Account -